Clinical Trials Sponsored by Massimo Imazio

Total 471 results

Mario Negri Institute for Pharmacological Research
Vifor Pharma

Recruiting

Patiromer Trial in CKD Stage IIIB to V

Hyperkalemia

Italy
The University of Hong Kong
Imago BioSciences,Inc.

Recruiting

Bomedemstat (IMG-7289) Plus Ruxolitinib for Myelofibrosis

Myelofibrosis

Hong Kong
Mario Negri Institute for Pharmacological Research
Alexion Pharmaceuticals

Completed

Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 Study

IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative Glomerulonephritis

Italy
Giovanni FM Strippoli, MD

Completed

The Clinical Evaluation of the Dose of Erythropoietins Trial (CEDOSE)

Kidney Failure, Chronic

Italy
Philips Electronics Nederland B.V. acting through...
suAzio N.V.

Completed

Norms and Validation for IntelliSpace Cognition Spanish Version

Cognitive Functioning of Healthy Individuals | Hispanic

United States
Mario Castro, MD, MPH

Recruiting

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

Asthma | Cystic Fibrosis | Pulmonary Hypertension | Interstitial Lung Disease | COPD | Pulmonary Infection | Other Lung Disease

United States
Mario Henrique Burlacchini de Carvalho

Unknown

Progesterone and Cervical Pessary in Twins (PRECEPET)

Preterm Birth | Twin Pregnancy With Antenatal Problem

Brazil
Mario Negri Institute for Pharmacological Research
EC-DG Research

Completed

Renal NCE-MRI in Healthy Volunteers

Healthy

Italy
Mario Negri Institute for Pharmacological Research
Heart Care Foundation

Completed

CYCLosporinE A in Reperfused Acute Myocardial Infarction (CYCLE)

Acute Myocardial Infarction

Italy
Mario Negri Institute for Pharmacological Research
Bristol-Myers Squibb

Completed

Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia (GiSAS)

Schizophrenia

Italy
Mario Negri Institute for Pharmacological Research
Leadiant Biosciences, Inc.

Completed

Acetyl-L-Carnitine in Type 2 Diabetes (DIABASI)

Hypertension | Diabetes Type 2

Italy
Mario Negri Institute for Pharmacological Research
Prime Care Physicians

Not yet recruiting

Anti-inflammatory Drug Algorithm for COVID-19 Home Treatment (COVER3)

COVID-19
Mario Negri Institute for Pharmacological Research
University of Pavia

Active, not recruiting

MuLtidimensional School-based and Family interVentions to Promote hEalthy and Sustainable LifestYle for the Childhood (LIVELY)

Childhood Obesity

Italy
Mario Negri Institute for Pharmacological Research
Laminate Medical Technologies

Completed

VasQ and Hemodynamic Conditions in AVFs (RESHAPE)

Renal Insufficiency, Chronic

Italy
Italian Sarcoma Group
Istituto Di Ricerche Farmacologiche Mario Negri

Completed

Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma (TRAVELL)

Leiomyosarcoma | Liposarcoma

Italy
University of Pisa
Azienda Ospedaliero, Universitaria Pisana; Imago 7

Unknown

EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI (EXLIPSE)

Liver Cirrhosis | Hepatocellular Carcinoma | Pancreatic Cancer | Magnetic Resonance Imaging | Liver Steatosis

Italy
Mario Negri Institute for Pharmacological Research
Hoffmann-La Roche

Active, not recruiting

Atezolizumab Trial in Endometrial Cancer - AtTEnd (AtTEnd)

Endometrial Cancer

New Zealand, Korea, Republic of, United Kingdom, Italy, Spain, Japan, Germany, Australia, Switzerland, Austria, Taiwan
Mario Negri Institute for Pharmacological Research
Roche Pharma AG

Active, not recruiting

Obinutuzumab in Primary MN (ORION)

Membranous Nephropathy

Italy
Istituto Clinico Humanitas
Istituto Di Ricerche Farmacologiche Mario Negri

Completed

Aging of Hematopoietic Stem Cells - Molecular Architecture of Marrow Dysplasia and Clinical Contribution of Ineffective Hematopoiesis to Frailty in the Elderly

Anemia | Clonal Hematopoiesis

Italy
Franciscus Gasthuis
Reinier de Graaf Groep; Ikazia Hospital, Rotterdam; Haga Medisch Centrum

Recruiting

High Flow Nasal Oxygen for Exacerbation COPD (HiCAP)

Acute Exacerbation of COPD

Netherlands
Fondazione Policlinico Universitario Agostino Gemelli...
Massimo Antonelli; Flavia Torrini; Alessandra Bisanti; Eleonora Filipponi; Domenica... and other collaborators

Recruiting

Patient Management During Major Abdominal Surgery: an Oxygen Consumption Protocol Compared to Standard Approach (HEART-CORE)

Hemodynamic Instability

Italy
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis (ARCADIA)

Hypertension | Left Ventricular Hypertrophy

Italy
Mario Negri Institute for Pharmacological Research
Hoffmann-La Roche; PharmaMar

Completed

Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer

Ovarian Epithelial Cancer Recurrent

Italy
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Preventing ESRD in Overt Nephropathy of Type 2 Diabetes (VALID)

Diabetes

Italy, Slovenia
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

E-learning to Improve the Quality of Drug Prescribing in Hospitalized Elderly Patients

Drug Use
Mario Negri Institute for Pharmacological Research
Istituto Superiore di Sanità

Completed

Preventing Renal Functional Abnormalities With Calorie Restriction in Subjects With Abdominal Obesity and Type 2 Diabetes at Increased Renal and Cardiovascular Risk (CRESO)

Diabetes Mellitus

Italy
Fondazione Policlinico Universitario Agostino Gemelli...
Antonio Maria Dell Anna; Sofia Cacciola; Claudio Sandroni; Giulia Chiuri; Mauro Pittiruti and other collaborators

Completed

Single-lumen 5Fr and Triple-lumen 6Fr PICCs Are Accurate for Hemodynamic Measurement by Transpulmonary Thermodilution.

Hemodynamic Monitoring | Peripherally Inserted Central Catheters | Centrally Inserted Central Catheter | Transpulmonary Thermodilution

Italy
University of Turin, Italy
Istituto Di Ricerche Farmacologiche Mario Negri

Not yet recruiting

Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation (PREVENTION)

Critical Illness | Respiratory Failure

France, Ireland, Italy
National Cancer Institute, Naples
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab (MITO16/MANGO-2)

Ovarian Cancer

Italy
National Cancer Institute, Naples
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer (MITO16MANGO2b)

Recurrent Ovarian Cancer

France, Italy, Switzerland, Monaco, Greece
Mario Negri Institute for Pharmacological Research
Otsuka Pharmaceutical Italy S.r.l.

Completed

Tolvaptan-Octreotide LAR Combination in ADPKD (TOOL)

Autosomal Dominant Polycystic Kidney Disease

Italy
Mario Negri Institute for Pharmacological Research
PharmaMar; Averion International Corporation

Completed

INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer (INOVATYON)

Ovarian Cancer

Austria, Belgium, Norway, Spain, Finland, United Kingdom, Italy, Denmark, Germany, Netherlands, Switzerland
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Preventing Microalbuminuria in Type 2 Diabetes (VARIETY)

Diabetes

Italy
Mario Negri Institute for Pharmacological Research
Alexion Pharma Italy s.r.l.

Completed

Eculizumab in Primary MPGN (EAGLE)

Membranoproliferative Glomerulonephritis

Italy
Mario Negri Institute for Pharmacological Research
Papa Giovanni XXIII Hospital

Not yet recruiting

Medical Images Collection Research (MEDICALBUM)

Brain Diseases | Kidney Diseases

Italy
Mario Negri Institute for Pharmacological Research
University of Sydney; FightMND

Not yet recruiting

Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS (ALCALS)

Amyotrophic Lateral Sclerosis
National Cancer Institute, Naples
Mario Negri Institute for Pharmacological Research

Recruiting

Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer (MITO28MaNGOov4)

Ovarian Cancer

Italy
Mario Arpinati
European Commission

Recruiting

Multiple Donor Treg DLI for Severe Refractory Chronic GVHD (TREG2015001)

Chronic Graft Versus Host Disease

Italy
Mario Negri Institute for Pharmacological Research
Istituto Superiore di Sanità

Completed

Effects of Caloric Restriction in Obesity and Type 2 Diabetes (CRESO2)

Obesity | Type 2 Diabetes

Italy
Oncologia Medica dell'Ospedale Fatebenefratelli
Mario Negri Institute for Pharmacological Research

Completed

PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment

Metastatic Breast Cancer | Toxicity | Neurotoxicity | Adverse Drug Event | Drug Toxicity

Italy
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

MMF vs. AZA for Kidney Transplantation (ATHENA)

Kidney Transplant

Italy
Associazione Volontari Pazienti Oncologici
Mario Negri Institute for Pharmacological Research

Completed

Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (H&N07)

Head and Neck Squamous Cell Carcinoma

Italy
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS) (NEMO)

Nephrotic Syndrome

Italy
Associazione Progetto Oncologia UMAN.A
Mario Negri Institute for Pharmacological Research

Completed

Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain

Pain | Cancer

Italy
Gianni Soraru
Mario Negri Institute for Pharmacological Research

Recruiting

A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy (BetaSBMA)

Spinal and Bulbar Muscular Atrophy

Italy
Mario Negri Institute for Pharmacological Research
Federico II University; IRCCS Multimedica

Completed

Proton Pump Inhibitors (PPI): a Study to Improve Appropriate Prescriptions in the Elderly (LAPTOP-PPI)

Proton Pump Inhibitor | Primary Care

Italy
Mario Negri Institute for Pharmacological Research
A.O. Ospedale Papa Giovanni XXIII

Terminated

Mesenchymal Stromal Cells in Kidney Transplant Recipients

Kidney Transplant Rejection

Italy
Regione Lombardia
Mario Negri Institute for Pharmacological Research; Istituto Clinico Humanitas

Unknown

Trastuzumab Optimization Trial in Breast Cancer (TOP)

Metastatic or Locally Advanced Breast Cancer

Italy
Mario Pérez Sayáns
Universidade da Coruña

Completed

Effects of Septorhinoplasty on Allergic Rhinitis

Allergic Rhinitis

Spain
Gruppo Oncologico del Nord-Ovest
Mario Negri Institute for Pharmacological Research

Unknown

Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Virus-Related Tumours (Dern)

Nasopharyngeal Carcinoma | EBV Related Carcinoma

Italy

Clinical Trials Sponsored by Massimo Imazio

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations